CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 35 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,786,000 | +610.7% | 482,816 | +153.4% | 0.01% | +600.0% |
| Q2 2016 | $392,000 | -3.9% | 190,527 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $408,000 | -25.7% | 190,527 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $549,000 | -35.3% | 190,527 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $848,000 | -23.9% | 190,527 | -12.0% | 0.00% | 0.0% |
| Q2 2015 | $1,115,000 | -27.7% | 216,587 | -0.1% | 0.00% | -33.3% |
| Q1 2015 | $1,543,000 | +1.2% | 216,791 | -0.4% | 0.00% | 0.0% |
| Q4 2014 | $1,524,000 | +14.3% | 217,762 | -0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,333,000 | -32.7% | 217,780 | +0.2% | 0.00% | -25.0% |
| Q2 2014 | $1,980,000 | +12.1% | 217,308 | +0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,767,000 | +25.4% | 217,264 | -0.5% | 0.00% | +33.3% |
| Q4 2013 | $1,409,000 | -35.9% | 218,406 | -0.2% | 0.00% | -50.0% |
| Q3 2013 | $2,199,000 | – | 218,822 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
| Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
| Quilter Plc | 60,546 | $19,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
| BlackRock Inc. | 645,611 | $200,000 | 0.00% |
| Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |